| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
4 |
/ |
2019 |
|
|
|
| |
Data sporządzenia: |
2019-10-04 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
List of Shareholders representing at least 5% of the number of votes at the Annual
General Meeting of the Shareholders on October 3, 2019
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 70 pkt 3 Ustawy o ofercie - WZA lista powyżej 5 %
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc, _“the "Company","the Issuer"_ hereby
informs that the entities named below were shareholders representing at least 5% of
the number of votes at the Annual General Meeting of Shareholders held in Livingston,
New Jersey, USA, on October 3, 2019 “the Meeting"
- Milestone Scientific Inc.- the shares held in the Company vested in Milestone Scientific
the right of 21,633,084 votes at the Meeting, which accounted for 100% of the votes
of the Shareholders present at the Meeting and for 98.33% of the total number of
votes.
|
|
|
RB_ASO: List of Shareholders representing at least 5% of the number of votes at the Annual
General Meeting of the Shareholders on October 3, 2019
